Business Context and Reporting Period
Company: Utah Medical Products, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 23, 2026
Reporting Period: The filing references financial information for the three months ended March 31, 2026, and forward-looking statements for 2026 and beyond.
Key Financial Metrics
The provided text is a cover sheet for a Form 8-K and does not contain specific numerical data. It states that financial information for the three months ended March 31, 2026, is attached as Exhibit 99.1 (a press release). Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not detail specific material changes versus prior periods. It indicates that such information is contained within the press release attached as Exhibit 99.1.
Guidance, Outlook, and Risks
- Outlook: The filing incorporates forward-looking statements relating to 2026 and beyond, which are presented in the attached press release (Exhibit 99.1).
- Legal Status: The information furnished pursuant to Item 2.02 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section.
- Emerging Growth Company: The registrant has not indicated it is an emerging growth company.
Investor Verification Checklist
- Review Exhibit 99.1 (the press release dated April 23, 2026) for actual revenue, profit, and cash flow figures for the quarter ended March 31, 2026.
- Verify the specific forward-looking statements and guidance for 2026 contained in the attached press release.
- Confirm the legal disclaimer that the financial data in this 8-K is furnished but not "filed" for liability purposes under Section 18 of the Exchange Act.